A Trial for Prevention of Recurrent Ischemic Priapism in Men With Sickle Cell Disease: A Pilot Study

NCT05142254 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Priapism Due to Sickle Cell Disease

Interventions

DRUG: Tadalafil
DRUG: Hydroxyurea
DRUG: Placebo

Sponsor

Vanderbilt University Medical Center